Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Milestone Pharmaceuticals Inc. (MIST) Wednesday announced that the FDA has accepted the Company's New Drug Application or NDA for Cardamyst nasal spray to manage paroxysmal supraventricular tachycardia or PSVT.
Press release - Shareholders Foundation, Inc. - Investigation ongoing for Investors in Xylem Inc. (NYSE: XYL) over potential Wrongdoing - published on openPR.com
Press release - Shareholders Foundation, Inc. - Lawsuit filed for Investors who lost money with shares of Inari Medical, Inc. (NASDAQ: NARI) - published on openPR.com
Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and Corporate Update marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Milestone Pharmaceuticals: Q1 Earnings Snapshot marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Critical Contrast: Cocrystal Pharma (NASDAQ:COCP) and Milestone Pharmaceuticals (NASDAQ:MIST) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Milestone Pharmaceuticals (NASDAQ:MIST – Get Free Report) and Cocrystal Pharma (NASDAQ:COCP – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership. Insider & Institutional Ownership 86.2% of Milestone […]
Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients' Ability to Self-Manage Recurring PSVT, Presented at The American College of Cardiology Annual Meeting tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.